Correlation Between Enveric Biosciences and Cidara Therapeutics
Can any of the company-specific risk be diversified away by investing in both Enveric Biosciences and Cidara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enveric Biosciences and Cidara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enveric Biosciences and Cidara Therapeutics, you can compare the effects of market volatilities on Enveric Biosciences and Cidara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enveric Biosciences with a short position of Cidara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enveric Biosciences and Cidara Therapeutics.
Diversification Opportunities for Enveric Biosciences and Cidara Therapeutics
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Enveric and Cidara is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Enveric Biosciences and Cidara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cidara Therapeutics and Enveric Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enveric Biosciences are associated (or correlated) with Cidara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cidara Therapeutics has no effect on the direction of Enveric Biosciences i.e., Enveric Biosciences and Cidara Therapeutics go up and down completely randomly.
Pair Corralation between Enveric Biosciences and Cidara Therapeutics
Given the investment horizon of 90 days Enveric Biosciences is expected to under-perform the Cidara Therapeutics. In addition to that, Enveric Biosciences is 2.04 times more volatile than Cidara Therapeutics. It trades about -0.54 of its total potential returns per unit of risk. Cidara Therapeutics is currently generating about -0.13 per unit of volatility. If you would invest 2,488 in Cidara Therapeutics on November 9, 2024 and sell it today you would lose (365.00) from holding Cidara Therapeutics or give up 14.67% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Enveric Biosciences vs. Cidara Therapeutics
Performance |
Timeline |
Enveric Biosciences |
Cidara Therapeutics |
Enveric Biosciences and Cidara Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enveric Biosciences and Cidara Therapeutics
The main advantage of trading using opposite Enveric Biosciences and Cidara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enveric Biosciences position performs unexpectedly, Cidara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cidara Therapeutics will offset losses from the drop in Cidara Therapeutics' long position.Enveric Biosciences vs. Ocean Biomedical | Enveric Biosciences vs. Hepion Pharmaceuticals | Enveric Biosciences vs. Elevation Oncology | Enveric Biosciences vs. Zura Bio Limited |
Cidara Therapeutics vs. CytomX Therapeutics | Cidara Therapeutics vs. Clearside Biomedical | Cidara Therapeutics vs. GlycoMimetics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Bonds Directory Find actively traded corporate debentures issued by US companies |